ORMAT (ORA) insider files Form 144 to sell 5,611 shares on NYSE

Rhea-AI Filing Summary

Form 144 notice for ORMAT TECHNOLOGIES, INC. (ORA) shows a proposed sale of 5,611 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $531,922.60, with an approximate sale date of 09/29/2025. The filing lists multiple underlying acquisitions: restricted stock grants on various dates in 2023, 2024 and 2025 totaling listed lots (e.g., 288, 313, 519, 393 shares) and a Stock Appreciation Rights award of 3,810 units on 09/29/2025 paid in cash. It also discloses a prior sale on 08/22/2025 of 692 shares for $65,442.44. Several standard signature and representation statements are included.

Positive

• Planned sale is clearly identified with broker, exchange, share count, aggregate value, and approximate sale date
• Lot-level acquisition details are provided (dates, nature of award, and amounts), aiding Rule 144 eligibility review
• Recent prior sale disclosed (692 shares on 08/22/2025 for $65,442.44), giving transaction context

Negative

• Key filer/issuer contact fields are blank or not shown in the provided extract (e.g., Filer CIK/CCC, contact name/phone/email)
• Issuer identification fields such as issuer address and SEC file number are not populated in the excerpt
• No information on percentage ownership or relationship impact is provided in the excerpt to assess materiality

Insights

Securities/Equity Analyst

TL;DR: Insiders plan a single brokered sale of 5,611 ORA shares valued at ~$532k on 09/29/2025; prior small sale occurred 08/22/2025.

The filing documents a planned Rule 144 disposition executed through Morgan Stanley Smith Barney, specifying the lot-level origins of the shares (restricted stock and SARs) and the cash nature of SAR proceeds. The disclosure of a recent sale (692 shares for $65,442.44) provides immediate trading context. The information is procedural and typical for insider liquidity under Rule 144; it does not include issuer financial results or broader strategic implications.

Compliance / Corporate Governance Expert

TL;DR: The Form 144 contains required sale scheduling and acquisition details but omits several issuer/filer contact identifiers in the filing text provided.

The form includes the required representations about lack of material nonpublic information and references Rule 10b5-1 language. It documents acquisition dates and payment nature for each lot, which supports Rule 144 eligibility assessment. However, the provided extract lacks explicit filer CIK/CCC and issuer address fields, which are normally present elsewhere in a complete filing; absent fields may hinder immediate verification without the full filing record.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5611	531922.60	60723470	09/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2025	Restricted Stock	ISSUER			288	03/01/2025	Not Applicable
Common	03/01/2024	Restricted Stock	ISSUER			288	03/01/2024	Not Applicable
Common	09/29/2025	Stock Appreciation Rights	ISSUER			3810	09/29/2025	Cash
Common	03/01/2023	Restricted Stock	ISSUER			313	03/01/2023	Not Applicable
Common	03/21/2024	Restricted Stock	ISSUER			519	03/21/2024	Not Applicable
Common	03/21/2025	Restricted Stock	ISSUER			393	03/21/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JESSICA WOELFEL 6884 Sierra Center Pkwy Reno NV 89511-2210	Common	08/22/2025	692	65442.44

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for ORA disclose about the proposed sale?

The filing discloses a proposed sale of 5,611 ORA common shares via Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $531,922.60, approx. sale date 09/29/2025.

What types of equity were the shares acquired as according to the filing?

The filing shows the shares were acquired as restricted stock on multiple dates (e.g., 03/01/2023, 03/01/2024, 03/01/2025, 03/21/2024, 03/21/2025) and as Stock Appreciation Rights on 09/29/2025 (3,810 units, paid in cash).

Was there any recent sale by the reported person prior to this proposed transaction?

Yes. The filing reports a prior sale of 692 shares on 08/22/2025 with gross proceeds of $65,442.44.

Does the filing state whether the seller knows any material nonpublic information?

Yes. By signing, the person represents they do not know any material adverse nonpublic information regarding the issuer at the time of the notice.

Through which broker and exchange will the sale be transacted?

The sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE.